DeepMind's Hassabis predicts singularity begins in 2026 with agentic AI
AGI just years away, 'solve all disease' by AI drug discovery
Demis Hassabis, CEO of Google DeepMind, made bold predictions at the India AI Impact Summit and Google I/O 2026. He stated that the 'singularity' — a point where AI surpasses human intelligence — could begin as early as 2026, driven by the rise of agentic AI systems that can autonomously plan and execute tasks. Hassabis emphasized that artificial general intelligence (AGI) is 'just a few years away,' likely arriving around 2030, not as a single breakthrough but as a series of incremental upgrades. This gradual evolution, he argued, will unlock 'unparalleled innovation' across every sector.
Hassabis also outlined DeepMind's grand ambition to 'solve all disease' using AI-powered drug discovery. By leveraging models capable of predicting protein structures and simulating molecular interactions, DeepMind hopes to dramatically accelerate the development of treatments for conditions like cancer, Alzheimer's, and rare genetic disorders. The company's AlphaFold already revolutionized structural biology, and its successor AlphaFold 3 aims to model entire cellular systems. While critics remain skeptical about the timeline for AGI, Hassabis's vision positions 2026 as a pivotal year for autonomous AI systems that could redefine healthcare, science, and society at large.
- Hassabis predicts singularity could begin in 2026 driven by autonomous agentic AI systems
- AGI expected around 2030 as a series of incremental upgrades, not a single event
- DeepMind aims to 'solve all disease' through AI drug discovery, building on AlphaFold's success
Why It Matters
If achieved, AGI and AI-driven drug discovery could redefine medicine and accelerate scientific progress by decades.